Hyperalgesia: an emerging iatrogenic syndrome.

PubWeight™: 0.91‹?›

🔗 View Article (PMID 12906962)

Published in J Pain Symptom Manage on August 01, 2003

Authors

Sebastiano Mercadante1, Patrizia Ferrera, Patrizia Villari, Edoardo Arcuri

Author Affiliations

1: Anesthesia and Intensive Care Unit & Pain Relief and Palliative Care Unit, La Maddalena Cancer Center, Palermo, Italy.

Articles by these authors

Gabapentin for neuropathic cancer pain: a randomized controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol (2004) 1.95

High doses of oxycodone-naloxone combination may provide poor analgesia. Support Care Cancer (2011) 1.65

CT-guided neurolytic splanchnic nerve block by an anterior approach. J Pain Symptom Manage (2002) 1.39

Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management. Eur J Pain (2008) 1.04

Frequency, indications, outcomes, and predictive factors of opioid switching in an acute palliative care unit. J Pain Symptom Manage (2009) 1.00

Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage (2004) 0.99

Addition of a second opioid may improve opioid response in cancer pain: preliminary data. Support Care Cancer (2004) 0.98

Optimization of opioid therapy for preventing incident pain associated with bone metastases. J Pain Symptom Manage (2004) 0.97

Peritoneal catheter for continuous drainage of ascites in advanced cancer patients. Support Care Cancer (2008) 0.97

Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage (2005) 0.96

The use of high doses of oxycodone in an acute palliative care unit. Am J Hosp Palliat Care (2010) 0.96

High-dose furosemide and small-volume hypertonic saline solution infusion for the treatment of leg edema in advanced cancer patients. J Pain Symptom Manage (2008) 0.96

A model of acute symptom control unit: Pain Relief and Palliative Care Unit of La Maddalena Cancer Center. Support Care Cancer (2002) 0.96

Opioid escalation in patients with cancer pain: the effect of age. J Pain Symptom Manage (2006) 0.95

Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids. Clin J Pain (2007) 0.93

Opioids and renal function. J Pain (2004) 0.93

Controlled sedation for refractory symptoms in dying patients. J Pain Symptom Manage (2008) 0.91

Tapentadol in cancer pain management: a prospective open-label study. Curr Med Res Opin (2012) 0.91

Pegylated liposomal doxorubicin with vinorelbine in metastatic breast carcinoma. A phase I-II clinical investigation. Oncology (2002) 0.90

Safety and effectiveness of intravenous morphine for episodic (breakthrough) pain using a fixed ratio with the oral daily morphine dose. J Pain Symptom Manage (2004) 0.90

Patients' and relatives' perceptions about intravenous and subcutaneous hydration. J Pain Symptom Manage (2005) 0.89

Long-term central venous catheterization via persistent left superior vena cava: a case report. Support Care Cancer (2003) 0.88

Safety and effectiveness of intravenous morphine for episodic breakthrough pain in patients receiving transdermal buprenorphine. J Pain Symptom Manage (2006) 0.87

Opioid-induced or pain relief-reduced symptoms in advanced cancer patients? Eur J Pain (2006) 0.87

Rapid titration with intravenous morphine for severe cancer pain and immediate oral conversion. Cancer (2002) 0.87

Low doses of transdermal fentanyl in opioid-naive patients with cancer pain. Curr Med Res Opin (2010) 0.85

Effects of red blood cell transfusion on anemia-related symptoms in patients with cancer. J Palliat Med (2009) 0.85

Hyperalgesia and opioid switching. Am J Hosp Palliat Care (2005) 0.85

Rapid switching between transdermal fentanyl and methadone in cancer patients. J Clin Oncol (2005) 0.84

Celiac plexus block for pancreatic cancer pain: factors influencing pain, symptoms and quality of life. J Pain Symptom Manage (2003) 0.84

Pharmacological management of cancer pain in the elderly. Drugs Aging (2007) 0.84

An Italian survey on the attitudes in treating breakthrough cancer pain in hospice. Support Care Cancer (2010) 0.84

The use of opioids for breakthrough pain in acute palliative care unit by using doses proportional to opioid basal regimen. Clin J Pain (2010) 0.84

Fentanyl buccal tablets for breakthrough pain in highly tolerant cancer patients: preliminary data on the proportionality between breakthrough pain dose and background dose. J Pain Symptom Manage (2011) 0.84

Low doses of transdermal buprenorphine in opioid-naive patients with cancer pain: a 4-week, nonrandomized, open-label, uncontrolled observational study. Clin Ther (2009) 0.83

Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients. J Pain (2009) 0.82

Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage (2006) 0.82

Burst ketamine to reverse opioid tolerance in cancer pain. J Pain Symptom Manage (2003) 0.81

Randomized double-blind, double-dummy crossover clinical trial of oral tramadol versus rectal tramadol administration in opioid-naive cancer patients with pain. Support Care Cancer (2005) 0.81

Pain syndromes in haematological malignancies: an overview. Hematol J (2004) 0.80

Outcome of opioid switching 4 weeks after discharge from a palliative care unit. Curr Med Res Opin (2011) 0.80

Local anesthetics for breakthrough pain in patients receiving intrathecal treatment for cancer pain management. Anesth Analg (2005) 0.80

Is there a ceiling effect of transdermal buprenorphine? Preliminary data in cancer patients. Support Care Cancer (2006) 0.80

Opioids in pain management of blood-related malignancies. Ann Hematol (2006) 0.79

When the progression of disease lowers opioid requirement in cancer patients. Clin J Pain (2010) 0.79

Does pain intensity predict a poor opioid response in cancer patients? Eur J Cancer (2011) 0.79

Withdrawal acute psychosis after corticosteroid discontinuation. J Pain Symptom Manage (2007) 0.79

The effects of low doses of pregabalin on morphine analgesia in advanced cancer patients. Clin J Pain (2013) 0.78

The use of fentanyl buccal tablets as breakthrough medication in patients receiving chronic methadone therapy: an open label preliminary study. Support Care Cancer (2010) 0.78

Tracheal stent to repair tracheal laceration after a double-lumen intubation. Ann Thorac Surg (2012) 0.78

Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a randomized placebo-controlled, double-blind crossover study. Tumori (2002) 0.77

Pain in malignant hematology. Expert Rev Hematol (2011) 0.77

Itraconazole-fentanyl interaction in a cancer patient. J Pain Symptom Manage (2002) 0.77

Refractory death rattle: deep aspiration facilitates the effects of antisecretory agents. J Pain Symptom Manage (2010) 0.77

Opioid switching and burst ketamine to improve the opioid response in patients with movement-related pain due to bone metastases. Clin J Pain (2009) 0.76

Prevalence of opioid-related dysuria in patients with advanced cancer having pain. Am J Hosp Palliat Care (2010) 0.76

The use of opioids in the last week of life in an acute palliative care unit. Am J Hosp Palliat Care (2010) 0.75

Effectiveness and tolerability of amidotrizoate for the treatment of constipation resistant to laxatives in advanced cancer patients. J Pain Symptom Manage (2010) 0.75

Beginning again from the end. Palliat Med (2008) 0.75

Sympathetic blocks and disease progression modifying pain mechanisms. Reg Anesth Pain Med (2003) 0.75

Switching from oxycodone to methadone in advanced cancer patients. Support Care Cancer (2011) 0.75

Intravenous morphine for breakthrough (episodic-) pain in an acute palliative care unit: a confirmatory study. J Pain Symptom Manage (2008) 0.75

A randomized-controlled study of intrathecal versus epidural thoracic analgesia in patients undergoing abdominal cancer surgery. J Clin Monit Comput (2008) 0.75